Table 1.
ST Group N=31 | CON Group N=31 | P valuea | |
---|---|---|---|
Age (years) | 66 ± 2 | 66 ± 1 | 0.76 |
Sex (male/female) | 21/10 | 19/12 | 0.59 |
BMI (kg/m2) | 30.9 ± 1.1 | 31.2 ± 1.0 | 0.81 |
Whole-Body Fat Mass (kg) | 35.0 ± 2.2 | 33.7 ± 2.4 | 0.70 |
Waist Circumference (cm) | 99.7 ± 2.3 | 100.1 ± 2.6 | 0.63 |
Fasting Glucose (mmol/L) | 8.79 ± 0.48 | 9.85 ± 0.69 | 0.21 |
Fasting Insulin (pmol/L) | 116 (124) | 115 (131) | 0.58 |
HOMA-IR | 7.1 (5.7) | 6.7 (9.0) | 0.96 |
Glycosylated Hb A1C (%) | 8.7 ± 0.3 | 8.4 ± 0.3 | 0.58 |
Diabetes Duration (y) | 8 ± 1 | 11 ± 1 | 0.22 |
Insulin Therapy (n) | 15 | 5 | 0.02 |
Data are mean ± SE except for not normally distributed variables (insulin and HOMA-IR) which show median (interquartile range).
a Baseline comparisons between groups were assessed by independent sample t-test comparisons for continuous and log transformed variables or Chi-square for categorical variables.